|
ADIPOR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.298630E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.768300E-02 |
| Normal-vs-Stage2 |
3.209400E-01 |
| Normal-vs-Stage3 |
3.021400E-01 |
| Normal-vs-Stage4 |
5.129400E-01 |
| Stage1-vs-Stage2 |
4.028000E-01 |
| Stage1-vs-Stage3 |
5.270800E-01 |
| Stage1-vs-Stage4 |
8.191400E-01 |
| Stage2-vs-Stage3 |
9.464600E-01 |
| Stage2-vs-Stage4 |
8.625000E-01 |
| Stage3-vs-Stage4 |
8.733800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.575600E-02 |
| Normal-vs-AfricanAmerican |
5.990600E-01 |
| Normal-vs-Asian |
5.907800E-01 |
| Caucasian-vs-AfricanAmerican |
2.782800E-01 |
| Caucasian-vs-Asian |
9.666400E-01 |
| AfricanAmerican-vs-Asian |
6.856200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.352400E-02 |
| Normal-vs-Female |
9.208000E-01 |
| Male-vs-Female |
3.020000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.726000E-02 |
| Normal-vs-Extreme_Weight |
2.307900E-02 |
| Normal-vs-Obese |
2.970400E-01 |
| Normal-vs-Extreme_Obese |
2.819600E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.564600E-01 |
| Normal_Weight-vs-Obese |
4.774200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.468800E-01 |
| Extreme_Weight-vs-Obese |
2.402800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.447400E-01 |
| Obese-vs-Extreme_Obese |
2.316800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.267600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.995200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.988100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.655500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.950800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.162400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.576340E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.753900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.570840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.352600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.140200E-01 |
| Normal-VS-Type2 PRCC |
1.330250E-02 |
| Normal-VS-KIRP CIMP |
7.447600E-01 |
| Normal-VS-Unclassified PRCC |
7.923400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.740400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.064200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.662200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.113840E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.330200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.106200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.708430E-02 |
| Normal-vs-N1 |
9.455800E-01 |
| Normal-vs-N2 |
1.180440E-01 |
| N0-vs-N1 |
1.356370E-01 |
| N0-vs-N2 |
3.474000E-02 |
| N1-vs-N2 |
4.539600E-01 |
|
|
